IP Verse

Emory University competitive analysis

Latest patents of Emory University opposed by its competitors

Explore Emory University's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2723354
Mar 24, 2021Compositions, Uses, And Preparation Of Platelet Lysates1
EP2397155
Dec 13, 2017Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)Pathway3
EP2133365
May 17, 2017Compositions And Methods For The Treatment Of Infections And Tumors1
EP2397156
Nov 2, 2016Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)Pathway5

Latest PTAB cases involving Emory University

Discover the latest PTAB cases involving Emory University, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Emory University with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EMORY UNIVERSITY - 10 - -
PFIZER761134412
REGENERON PHARMACEUTICALS55153932
SANOFI7126 - -